Clark Ian T. - 29 Jun 2021 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role: Director
Signature: /s/ John Saia, as attorney-in-fact for Ian T. Clark
Issuer symbol: GH
Transactions as of: 29 Jun 2021
Net transactions value: -$995,057
Form type: 4
Filing time: 01 Jul 2021, 17:04:28 UTC
Previous filing: 21 Jun 2021
Next filing: 03 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GH	COMMON STOCK	Options Exercise	$4,498	+1,076	+23%	$4.18	5,719	29 Jun 2021	Direct
transaction	GH	COMMON STOCK	Options Exercise	$373,116	+4,840	+85%	$77.09	10,559	29 Jun 2021	Direct
transaction	GH	COMMON STOCK	Sale	$1,372,670	-10,559	-100%	$130.00	0	29 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GH	STOCK OPTION (RIGHT TO BUY)	Options Exercise	$0	-1,076	-33%	$0.000000	2,152	29 Jun 2021	COMMON STOCK	1,076	$4.18	Direct	F2
transaction	GH	STOCK OPTION (RIGHT TO BUY)	Options Exercise	$0	-4,840	-100%	$0.000000^*	0	29 Jun 2021	COMMON STOCK	4,840	$77.09	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2	The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on October 25, 2017.
F3	The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders.